Cite
HARVARD Citation
Bauer, T. et al. (2013). Carbohydrate antigen 19‐9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine‐containing chemotherapy. Cancer. 119 (2), pp. 285-292. [Online].